Spontaneous beta(2)-adrenergic signaling fails to modulate L-type Ca2+ current in mouse ventricular myocytes
YY Zhou,HP Cheng,LS Song,DJ Wang,EG Lakatta,RP Xiao
DOI: https://doi.org/10.1124/mol.56.3.485
1999-01-01
Molecular Pharmacology
Abstract:A receptor can be activated either by specific ligand-directed changes in conformation or by intrinsic, spontaneous conformational change. In the beta(2)-adrenergic receptor (AR) overexpression transgenic (TG4) murine heart, spontaneously activated beta(2)AR (beta(2)-R*) in the absence of ligands has been evidenced by elevated basal adenylyl cyclase activity and cardiac function. In the present study, we determined whether the signaling mediated by beta(2)-R* differs from that of a ligand-elicited beta(2)AR activation (beta(2)-LR*). In ventricular myocytes from TG4 mice, the properties of L-type Ca2+ current (I-Ca), a major effector of beta(2)-LR* signaling, was unaltered, despite a 2.5-fold increase in the basal cAMP level and a 1.9-fold increase in baseline contraction amplitude as compared with that of wildtype (WT) cells. Although the contractile response to beta(2)-R* in TG4 cells was abolished by a beta(2)AR inverse agonist, ICI118,551 (5 x 10(-7) M), or an inhibitory cAMP analog, Rp-CPT-cAMPS (10(-4) M), no change was detected in the simultaneously recorded I-Ca. These results suggest that the increase in basal cAMP due to beta(2)-R*, while increasing contraction amplitude, does not affect I,, characteristics. In contrast, the beta(2)AR agonist, zinterol elicited a substantial augmentation of I-Ca in both TG4 and WT cells (pertussis toxin-treated), indicating that L-type Ca2+ channel in these cells can respond to ligand-directed signaling. Furthermore, forskolin, an adenylyl cyclase activator, elicited similar dose-dependent increase in I-Ca amplitude in WT and TG4 cells, suggesting that the sensitivity of L-type Ca2+ channel to cAMP-dependent modulation remains intact in TG4 cells. Thus, we conclude that beta(2)R* bypasses I-Ca to modulate contraction, and that beta(2)-LR* and beta(2)-R* exhibit different intracellular signaling and target protein specificity.